US FDA approves pre-filled version of GSK's shingles vaccine
17/07/2025 12:04
July 17 (Reuters) - The U.S. Food and Drug Administration approved a pre-filled syringe version of GSK's GSK.L blockbuster shingles vaccine Shingrix, providing patients a more convenient option to receive the shot, the company said on Thursday. (Reporting by Siddhi Mahatole and Christy Santhosh in Bengaluru; Editing by Shilpi Majumdar) ((siddhi.mahatole@thomsonreuters.com))
Recent news on Dynavax Technologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
OneSpaWorld jumps as co poised to join S&P SmallCap index
Sanofi targets high single digit sales growth in 2026, plans share buyback (updated)
Focus: Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality